Flavonoids as promoters of the (pseudo-)halogenating activity of lactoperoxidase and myeloperoxidase.

[1]  J. Flemmig,et al.  Lactoperoxidase as a potential drug target , 2016, Expert opinion on therapeutic targets.

[2]  C. Obinger,et al.  Enhancing hypothiocyanite production by lactoperoxidase – mechanism and chemical properties of promotors , 2015, Biochemistry and biophysics reports.

[3]  J. Flemmig,et al.  Leonurus cardiaca L. herb extracts and their constituents promote lactoperoxidase activity , 2015 .

[4]  S. Hofbauer,et al.  Independent evolution of four heme peroxidase superfamilies , 2015, Archives of biochemistry and biophysics.

[5]  J. Chandler,et al.  Biochemical mechanisms and therapeutic potential of pseudohalide thiocyanate in human health , 2015, Free radical research.

[6]  M. Jijakli,et al.  Mode of Action of Lactoperoxidase as Related to Its Antimicrobial Activity: A Review , 2014, Enzyme research.

[7]  A. Kettle,et al.  Uric Acid and Thiocyanate as Competing Substrates of Lactoperoxidase* , 2014, The Journal of Biological Chemistry.

[8]  J. Flemmig,et al.  Components of a standardised olive leaf dry extract (Ph. Eur.) promote hypothiocyanite production by lactoperoxidase. , 2014, Archives of biochemistry and biophysics.

[9]  G. O. Bonilla-Rodriguez,et al.  Immobilization of a Plant Lipase from Pachira aquatica in Alginate and Alginate/PVA Beads , 2014, Enzyme research.

[10]  G. Pairaudeau,et al.  Potent Reversible Inhibition of Myeloperoxidase by Aromatic Hydroxamates* , 2013, The Journal of Biological Chemistry.

[11]  Sujata Sharma,et al.  Lactoperoxidase: structural insights into the function,ligand binding and inhibition. , 2013, International journal of biochemistry and molecular biology.

[12]  J. Chandler,et al.  Thiocyanate: a potentially useful therapeutic agent with host defense and antioxidant properties. , 2012, Biochemical pharmacology.

[13]  T. R. Middya,et al.  A QSAR study of radical scavenging antioxidant activity of a series of flavonoids using DFT based quantum chemical descriptors – the importance of group frontier electron density , 2012, Journal of Molecular Modeling.

[14]  G. Stoner,et al.  Effects of Human Oral Mucosal Tissue, Saliva, and Oral Microflora on Intraoral Metabolism and Bioactivation of Black Raspberry Anthocyanins , 2011, Cancer Prevention Research.

[15]  M. Davies.  Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention , 2010, Journal of clinical biochemistry and nutrition.

[16]  I. Gülçin,et al.  Interactions of melatonin and serotonin with lactoperoxidase enzyme , 2010, Journal of enzyme inhibition and medicinal chemistry.

[17]  J. Arnhold,et al.  Human myeloperoxidase in innate and acquired immunity. , 2010, Archives of biochemistry and biophysics.

[18]  M. Serafini,et al.  Flavonoids as anti-inflammatory agents , 2010, Proceedings of the Nutrition Society.

[19]  Sujata Sharma,et al.  First structural evidence for the mode of diffusion of aromatic ligands and ligand-induced closure of the hydrophobic channel in heme peroxidases , 2010, JBIC Journal of Biological Inorganic Chemistry.

[20]  C. Obinger,et al.  (-)-Epicatechin enhances the chlorinating activity of human myeloperoxidase. , 2010, Archives of biochemistry and biophysics.

[21]  Szilvia Szép,et al.  The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases , 2009, Proceedings of the National Academy of Sciences.

[22]  Sujata Sharma,et al.  Inhibition of lactoperoxidase by its own catalytic product: crystal structure of the hypothiocyanate-inhibited bovine lactoperoxidase at 2.3-A resolution. , 2009, Biophysical journal.

[23]  C. Obinger,et al.  Kinetic evidence for rapid oxidation of (-)-epicatechin by human myeloperoxidase. , 2008, Biochemical and biophysical research communications.

[24]  Ł. Minarowski,et al.  Thiocyanate concentration in saliva of cystic fibrosis patients. , 2008, Folia histochemica et cytobiologica.

[25]  D. Ferreira,et al.  Theoretical calculation of electronic circular dichroism of the rotationally restricted 3,8''-biflavonoid morelloflavone. , 2007, The Journal of organic chemistry.

[26]  Sujata Sharma,et al.  Crystal structure of lactoperoxidase at 2.4 A resolution. , 2007, Journal of molecular biology.

[27]  M. Tao,et al.  Circadian rhythm of salivary serotonin in patients with major depressive disorder. , 2007, Neuro endocrinology letters.

[28]  D. Glossman-Mitnik,et al.  Theoretical study of the molecular properties and chemical reactivity of (+)-catechin and (−)-epicatechin related to their antioxidant ability , 2006 .

[29]  C. Obinger,et al.  Active site structure and catalytic mechanisms of human peroxidases. , 2006, Archives of biochemistry and biophysics.

[30]  C. Obinger,et al.  Reaction of ferrous lactoperoxidase with hydrogen peroxide and dioxygen: an anaerobic stopped-flow study. , 2005, Archives of biochemistry and biophysics.

[31]  M. Ashby,et al.  Redox buffering of hypochlorous acid by thiocyanate in physiologic fluids. , 2004, Journal of the American Chemical Society.

[32]  C. Obinger,et al.  Direct conversion of ferrous myeloperoxidase to compound II by hydrogen peroxide: an anaerobic stopped-flow study. , 2003, Biochemical and biophysical research communications.

[33]  C. Obinger,et al.  Redox properties of the couples compound I/compound II and compound II/native enzyme of human myeloperoxidase. , 2003, Biochemical and biophysical research communications.

[34]  E. Laurenti,et al.  Organic and inorganic substrates as probes for comparing native bovine lactoperoxidase and recombinant human myeloperoxidase. , 2003, Journal of inorganic biochemistry.

[35]  C. Obinger,et al.  Reaction of lactoperoxidase compound I with halides and thiocyanate. , 2002, Biochemistry.

[36]  C. Obinger,et al.  Redox intermediates of plant and mammalian peroxidases: a comparative transient-kinetic study of their reactivity toward indole derivatives. , 2002, Archives of biochemistry and biophysics.

[37]  P. O'Brien,et al.  Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation. , 2001, Free radical biology & medicine.

[38]  C. Obinger,et al.  Two‐electron reduction and one‐electron oxidation of organic hydroperoxides by human myeloperoxidase , 2000, FEBS letters.

[39]  A. V. van Hooijdonk,et al.  Lactoperoxidase: physico-chemical properties, occurrence, mechanism of action and applications , 2000, British Journal of Nutrition.

[40]  R. Fenna,et al.  X-ray Crystal Structure and Characterization of Halide-binding Sites of Human Myeloperoxidase at 1.8 Å Resolution* , 2000, The Journal of Biological Chemistry.

[41]  C. Obinger,et al.  Transient and Steady-state Kinetics of the Oxidation of Substituted Benzoic Acid Hydrazides by Myeloperoxidase* , 1999, The Journal of Biological Chemistry.

[42]  C. Obinger,et al.  Reaction of myeloperoxidase compound I with chloride, bromide, iodide, and thiocyanate. , 1998, Biochemistry.

[43]  G. Kerkhof,et al.  Correlation between concentrations of melatonin in saliva and serum in patients with delayed sleep phase syndrome. , 1998, Therapeutic drug monitoring.

[44]  A. Kettle,et al.  Thiocyanate and chloride as competing substrates for myeloperoxidase. , 1997, The Biochemical journal.

[45]  D. Dawson,et al.  Salivary Melatonin as a Circadian Phase Marker: Validation and Comparison to Plasma Melatonin , 1997, Journal of Biological Rhythms.

[46]  B. W. Clare.  Charge transfer complexes and frontier orbital energies in QSAR: a congeneric series of electron acceptors , 1995 .

[47]  C. Rice-Evans,et al.  Antioxidant activity of saliva and periodontal disease. , 1994, Free radical research.

[48]  F. Lagerlöf.  Caries-Protective Factors in Saliva , 1994, Advances in dental research.

[49]  M. Quirynen,et al.  Effect of a lactoperoxidase containing toothpaste in radiation-induced xerostomia. , 1994, International dental journal.

[50]  H. Dunford,et al.  Spectral and kinetic studies on the formation of myeloperoxidase compounds I and II: roles of hydrogen peroxide and superoxide. , 1994, Biochemistry.

[51]  V. H. Lee,et al.  Drug metabolism in the oral cavity , 1993 .

[52]  F. Rahemtulla,et al.  Quantitative, standardized assays for determining the concentrations of bovine lactoperoxidase, human salivary peroxidase, and human myeloperoxidase. , 1990, Analytical biochemistry.

[53]  R. Arnold,et al.  Inhibition of dental plaque acid production by the salivary lactoperoxidase antimicrobial system , 1981, Infection and immunity.

[54]  M. Jefferson,et al.  Hypothiocyanite Ion: Detection of the Antimicrobial Agent in Human Saliva , 1980, Journal of dental research.

[55]  J. Flemmig,et al.  (-)-Epicatechin regenerates the chlorinating activity of myeloperoxidase in vitro and in neutrophil granulocytes. , 2014, Journal of inorganic biochemistry.

[56]  Liangliang Xie,et al.  Characterization and density functional theory study of the antioxidant activity of quercetin and its sugar-containing analogues , 2013, European Food Research and Technology.

[57]  A. Kettle,et al.  Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione. , 2009, The Biochemical journal.

[58]  T. Walle,et al.  Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. , 2005, The Journal of nutrition.

[59]  F. Tomás-Barberán,et al.  Flavonoids in Food and Their Health Benefits , 2004, Plant foods for human nutrition.

[60]  C. Rice-Evans,et al.  Structure-antioxidant activity relationships of flavonoids and phenolic acids. , 1996, Free radical biology & medicine.

[61]  J. Robinson,et al.  Drug delivery via the mucous membranes of the oral cavity. , 1992, Journal of pharmaceutical sciences.

[62]  H. Hoogendoorn,et al.  Lactoperoxidase in the prevention of plaque accumulation, gingivitis and dental caries. I. Effect on oral streptococci and lactobacilli. , 1973, Odontologisk revy.